POST-APPROVAL SAFETY STUDY (PASS) OF THE UTILIZATION PATTERN OF APIXABAN IN THE NETHERLANDS

First published 18/11/2013

Last updated 14/03/2024

EU PAS number:

EUPAS5184

Study

Finalised

Documents

Study protocol

Initial protocol

cv185102st-prot (pfizer-protocol-b0661018)

English (123.8 KB - PDF) View document

Updated protocol

cv185102st-prot-may2015-(pfizer-protocol-b0661018)-red

First published: 22/02/2024

English (1.7 MB - PDF) View document

Study results

study-cv185102st-csr-final-red

English (1000.57 KB - PDF) View document

Study report

Other information

Secondary tabs